US Stock MarketDetailed Quotes

CRSP CRISPR Therapeutics

Watchlist
  • 53.910
  • +0.180+0.34%
Close Apr 26 16:00 ET
  • 54.110
  • +0.200+0.37%
Post 19:59 ET
4.58BMarket Cap-27788P/E (TTM)

CRISPR Therapeutics Key Stats

CRISPR Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

201.21M

+3353333.33%
EPS(YoY)

1.13

+180.14%

Buy

Apr 18, 2024

CRISPR Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 20 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 10.989M--
--2024/Q1-- / 25.169M--
--2023/Q4201.206M / 123.085M--
--2023/Q30.000 / 7.956M--
--2023/Q270.000M / 1.620M--
--2023/Q1100.000M / 24.329M--
--2022/Q46.000K / 7.365M--
--2022/Q394.000K / 536.540K--
--2022/Q2158.000K / 2.198M--
--2022/Q1940.000K / 2.450M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 10.989M--
--2024/Q1-- / 25.169M--
--2023/Q4201.206M / 123.085M--
--2023/Q30.000 / 7.956M--
--2023/Q270.000M / 1.620M--
--2023/Q1100.000M / 24.329M--
--2022/Q46.000K / 7.365M--
--2022/Q394.000K / 536.540K--
--2022/Q2158.000K / 2.198M--
--2022/Q1940.000K / 2.450M--

Unlock Free Earnings Estimates

CRISPR Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 18, 2024

Buy

  • Buy

    58.82%
  • Hold

    29.41%
  • Sell

    11.77%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg